FR2100798A1 - - Google Patents

Info

Publication number
FR2100798A1
FR2100798A1 FR7122365A FR7122365A FR2100798A1 FR 2100798 A1 FR2100798 A1 FR 2100798A1 FR 7122365 A FR7122365 A FR 7122365A FR 7122365 A FR7122365 A FR 7122365A FR 2100798 A1 FR2100798 A1 FR 2100798A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7122365A
Other languages
French (fr)
Other versions
FR2100798B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of FR2100798A1 publication Critical patent/FR2100798A1/fr
Application granted granted Critical
Publication of FR2100798B1 publication Critical patent/FR2100798B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/10—Aza-phenanthrenes
FR7122365A 1970-06-19 1971-06-18 Expired FR2100798B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2990570 1970-06-19

Publications (2)

Publication Number Publication Date
FR2100798A1 true FR2100798A1 (en) 1972-03-24
FR2100798B1 FR2100798B1 (en) 1975-10-10

Family

ID=10299112

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7122365A Expired FR2100798B1 (en) 1970-06-19 1971-06-18

Country Status (3)

Country Link
DE (1) DE2130408A1 (en)
FR (1) FR2100798B1 (en)
GB (1) GB1334705A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003010146A1 (en) * 2001-07-20 2003-02-06 Neuro3D Compositions derived from quinoline and quinoxaline, preparation and use thereof

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3865831A (en) * 1972-06-09 1975-02-11 Upjohn Co 1,1{40 ,4,4{40 -tetrahydro-4,4{40 -dioxo(6,6{40 biquinoline)-2,2{40 -dicarboxylates
US4281131A (en) 1977-06-20 1981-07-28 Sandoz, Inc. 4-Hydroxy-2-quinolinone-3-carboxylic acids and salts thereof
US4273930A (en) * 1977-06-20 1981-06-16 Sandoz, Inc. 4-Hydroxy-2-quinolinone-3-carboxylic acid esters
US4128649A (en) 1977-06-29 1978-12-05 Sandoz, Inc. 4-Hydroxy-pyrido[2,3-b]pyridine-2(1H)-one-3-carboxylic acids and esters
EP0062001B1 (en) * 1981-03-24 1987-05-27 Ciba-Geigy Ag Acyl quinolinone derivatives, processes for their preparation, pharmaceutical compositions containing them and their use
DE3773240D1 (en) * 1986-03-28 1991-10-31 Otsuka Pharma Co Ltd HYDROCHINOLIN COMPOUNDS, THE COMPOSITIONS CONTAINING THEM, AND METHOD FOR THE PRODUCTION THEREOF.
GB8719102D0 (en) * 1987-08-12 1987-09-16 Merck Sharp & Dohme Therapeutic agents
US5270309A (en) * 1987-08-12 1993-12-14 Merck Sharp & Dohme Limited Kynurenic acid derivatives useful in the treatment of neurodegenerative disorders
US4968701A (en) * 1988-04-26 1990-11-06 E. I. Du Pont De Nemours And Company 4-Quinoline carboxylic acid derivatives useful as immunosuppressive agents
US5204329A (en) * 1990-06-11 1993-04-20 Du Pont Merck Pharmaceutical Company Treatment of organ transplantation rejection
US6861424B2 (en) 2001-06-06 2005-03-01 Schering Aktiengesellschaft Platelet adenosine diphosphate receptor antagonists
DE60333866D1 (en) 2002-12-11 2010-09-30 Bayer Schering Pharma Ag 2-AMINOCARBONLYL-CHINOLINE COMPOUNDS AS ADENOSINE DIPHOSPHATE PLATEN RECEPTOR ANTAGONISTS
US8697674B2 (en) 2004-12-29 2014-04-15 Naturon, Inc. Xanthurenic acid derivative pharmaceutical compositions and methods related thereto
HUP0900281A2 (en) * 2009-05-05 2011-01-28 Univ Szegedi Kynurenc acid derivatives, process for their preparation, pharmaceutical compositions containing them and their use for the treatment of headache

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1913466A1 (en) * 1968-03-18 1969-11-06 Warner Lambert Pharmaceutical Antiviral compositions containing quinoline derivatives

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1913466A1 (en) * 1968-03-18 1969-11-06 Warner Lambert Pharmaceutical Antiviral compositions containing quinoline derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003010146A1 (en) * 2001-07-20 2003-02-06 Neuro3D Compositions derived from quinoline and quinoxaline, preparation and use thereof

Also Published As

Publication number Publication date
DE2130408A1 (en) 1971-12-23
GB1334705A (en) 1973-10-24
FR2100798B1 (en) 1975-10-10

Similar Documents

Publication Publication Date Title
AR204384A1 (en)
FR2100798B1 (en)
ATA96471A (en)
AU1146470A (en)
AU1473870A (en)
AU1326870A (en)
AU1716970A (en)
AU1517670A (en)
AU1336970A (en)
AR195465A1 (en)
AU442358B2 (en)
AU1581370A (en)
AU1689770A (en)
ATA672271A (en)
AU2115870A (en)
AU1277070A (en)
AU1247570A (en)
AU1235770A (en)
AU1343870A (en)
AU1189670A (en)
AU1064870A (en)
AU1086670A (en)
AU1083170A (en)
AU1004470A (en)
AU1591370A (en)

Legal Events

Date Code Title Description
ST Notification of lapse